The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Vascular Endothelial Growth Factor (VEGF) and its receptor KDR are involved in the regulation of angiogenesis and are up-regulated in a number of tumours in humans and in particular, breast cancer. We therefore evaluated the prognostic potential of the angiogenetic process in feline and canine mammary carcinomas by the immunohistochemical assessment of VEGF expression and micro vessel density (MVD) quantification and examined the interplay between VEGF and KDR. These variables were related to some relevant clinicopathological parameters and to overall survival (OS). VEGF and KDR expression were evaluated in epithelial, stromal and endothelial compartments in order to identify autocrine and/or paracrine loops. In dogs an increased VEGF expression did not show any statistical correlation with the clinicopathological parameters examined and was not correlated to a poorer prognosis. MVD was found to be significantly correlated to the histologic type (P=0.04), tumour grading (P=0.02), and to the OS (P=0.01). In cats VEGF expression was significantly correlated to tumor grading (P=0.01) and OS (P=0.03), while no significant associations were found between MVD and the other parameters. VEGF and KDR were found to be detected on the epithelial, and/or endothelial and/or stromal cells of the carcinomas in both species, suggesting indications for some possible autocrine and paracrine loops. Our results encourage further studies on the possible prognostic role of VEGF and MVD in canine and feline mammary tumours and on the role of growth factors and their receptors in promoting tumour proliferation and an "angiogenetic shift". The VEGF/KDR system may play a role in malignant transformation and tumor progression.
Department of Animal Pathology, School of Veterinary Medicine, University of Pisa, Viale delle Piagge 2, I-56124 Pisa, Italy.
F
F
Millanta
G
G
Silvestri
C
C
Vaselli
S
S
Citi
G
G
Pisani
D
D
Lorenzi
A
A
Poli
D000818:Animals; D019898:Autocrine Communication / Q000502:physiology; D002277:Carcinoma / Q000378:metabolism / Q000662:veterinary*; D002371:Cat Diseases / Q000378:metabolism; D002415:Cats; D002478:Cells, Cultured; D004283:Dog Diseases / Q000378:metabolism; D004285:Dogs; D005260:Female; D015674:Mammary Neoplasms, Animal / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000662:veterinary*; D019899:Paracrine Communication / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*
D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2